首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of psychoactive drugs

缩写:

ISSN:0279-1072

e-ISSN:2159-9777

IF/分区:2.4/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引705
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Joaquín Rodríguez-Ruíz,Bryan Lee Miller,Raquel Espejo-Siles et al. Joaquín Rodríguez-Ruíz et al.
Mental health promotion and substance use prevention are essential issues at universities worldwide. Although research has identified risk and protective factors for substance use generally among college students, there is a paucity of know...
Daniel Perkins,Jerome Sarris,Tessa Cowley-Court et al. Daniel Perkins et al.
Emerging evidence indicates that ayahuasca consumption may have beneficial mental health effects. This study undertakes the largest analysis to date of associations between naturalistic ayahuasca use and current mental health status via an ...
Wesley C Ryan,Boris D Heifets Wesley C Ryan
The use of ketamine and ketamine-assisted psychotherapy (KAP) for treatment of depression has grown dramatically, though much of these data are short term. The clinical profile of maintenance treatment remains poorly characterized. We asses...
Cavid Guliyev,Ebru Aldemir,Melike Şimşek et al. Cavid Guliyev et al.
Evidence suggests that individuals who use methamphetamine are at a significantly higher risk of developing psychosis compared to non-users. This study aims to examine the rate of psychosis among methamphetamine users and to investigate fac...
Kevin F Boehnke,Daniel J Kruger,Carrie Cuttler et al. Kevin F Boehnke et al.
Presently, 24 states have legalized adult use (recreational) cannabis, each following medical-only access. Although states that pass adult use laws report substantial declines in the number of registered medical patients, these laws expand ...
Pouya Azar,Victor W Li,James S H Wong et al. Pouya Azar et al.
Buprenorphine is an effective treatment for opioid use disorder but can be slow when using a standard low-dose titration protocol to avoid precipitated withdrawal. This presents a substantial practical barrier in clinical practice. Recent l...
Reza Ghaffarzadegan,Mokhtar Karimi,Behnaz Hedayatjoo et al. Reza Ghaffarzadegan et al.
Psilocybin-containing mushrooms, commonly known as magic mushrooms, drastically affect mental processing, cognitive functioning, and the mood state. In the present study, we investigated the effect of the Psilocybe cubensis extract on spati...
Surabhi Gupta,Renjith R Pillai,Abhishek Ghosh Surabhi Gupta
Alcohol misuse is common in persons on opioid agonist maintenance treatment (OAMT). We tested the efficacy of screening and brief intervention (SBI) for harmful/hazardous alcohol use in buprenorphine/naloxone (BNX)-assisted OAMT. It was a d...
Chijie Wang,Qian Lu,Boyu Li et al. Chijie Wang et al.
Many methadone maintenance treatment (MMT) participants experienced a tapering phase. The benefit of tapering is based on a balance between meeting the desire to reduce methadone dose and reduction in relapse. We aimed to develop and valida...
Jake Scarcella,Jeffrey MacDaniels,Lucinda Coffin et al. Jake Scarcella et al.
Esketamine, the isolated S-enantiomer of ketamine, has been a recent breakthrough as a non-monoaminergic treatment for treatment-resistant depression (TRD). This case report explores a rare adverse event in a 41-year-old female with TRD, wh...